群益证券给予联影医疗“买进”评级：2025年净利YOY+50%，符合预期

Group 1 - The core viewpoint of the report is that Guoying Securities has given a "Buy" rating to United Imaging Healthcare (688271.SH) based on its strong performance and growth prospects [1] - The company reported a revenue of 13.82 billion yuan for 2025, representing a year-on-year increase of 34.2% [1] - The net profit attributable to shareholders reached 1.89 billion yuan, up 49.6% year-on-year, while the net profit after deducting non-recurring items was 1.79 billion yuan, reflecting a significant increase of 77.0% year-on-year [1] Group 2 - The company continues to benefit from the ongoing implementation of equipment upgrade policies in the domestic market [1] - There is a strengthening of overseas market expansion efforts [1]